Drugs Policy in Developing Countries

Nazneen Kanji · Anita Petra Hardon · J. W. Harnmeijer · Masuma Mamdani · Gerrit Van der Waldt

47 citations0/0 files stored

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Systems and Reforms Global Public Health Policies and Epidemiology

Abstract

Tables and Figures Contributors Foreword and Acknowledgements Acronyms and Abbreviations 1. Early Initiatives in Essential Drugs Policy - Masuma Mamdani 2. Formulating an Essential Drugs Policy: WHO's Role - Gill Walt and Jan Willem Harnmeijer 3. Consumers versus Producers: Power Play Behind the Scenes - Anita Hardon 4. Action at Country Level: The International and National Influences - Najmi Kanji 5. What Has Been Achieved and Where are We Now? - Najmi Kanji and Anita Hardon 6. New Horizons in the 1990s - Anita Hardon and Najmi Kanji Appendix Index

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 47 citations exist upstream.

Cited by

2003Social Lives of Medicines

Imported from OpenAlex (CC0) — nothing here is generated.